Effect of Unani drug in Heart disease risk factors
Phase 2
- Conditions
- Health Condition 1: null- clinical and laboratrical diagnosed patients of Dyslipidaemia and Hypertension
- Registration Number
- CTRI/2018/05/013761
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient of both gender age 30-60 years.
2.Pre - hypertensive 120-139 or 80-90 mm Hg.
3.BMI >= 25 kg/m2.
4.Serum triglyceride ( 150-499 mg/dl).
5.Serum cholesterol (200- 240 mg/dl).
6.HDL cholesterol ( men > 40 mg/dl),( women > 50 mg/dl).
Exclusion Criteria
1.Patients below the age of 30 years and above 60 years.
2.Uncontrolled Blood Pressure.
3.Diabetic patients.
4.Pregnant and lactating women.
5Patients of other co- morbidities taking medicine.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurement of Blood Pressure and BMI <br/ ><br>Timepoint: at 0th, 15th, 30th, 45th and 60th days
- Secondary Outcome Measures
Name Time Method MDA (Lipid per oxidation test) <br/ ><br>Lipid profileTimepoint: at 0 and 60th day